Paper840296
Early presence of ribonucleoprotein antigen on surface of influenza virus-infected cells.
Virelizier JL and 3 others. Nature, 1977. Cited by 92 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Early presence of ribonucleoprotein antigen on surface of influenza virus-infected cells. Papers, record 840296. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/840296
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Early presence of ribonucleoprotein antigen on surface of influenza virus-infected cells.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, Viral | Major topic |
| Influenza A virus | Major topic |
| Influenza, Human | Major topic |
| Nucleoproteins | Major topic |
| Cell Line | |
| Cell Membrane | |
| Humans | |
| Ribonucleoproteins | |
| Time Factors |
Source PubMed
References11
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4,625,019 | Polypeptide synthesis in influenza virus-infected cells. | Virology | 1972 | https://conductscience.org/library/papers/4625019 | PubMed |
| 3 | 807,637 | Host defenses against influenza virus: the role of anti-hemagglutinin antibody. | J Immunol | 1975 | https://conductscience.org/library/papers/807637 | PubMed |
| 4 | 4,914,627 | Developmental sequence and intracellular sites of synthesis of three structural protein antigens of influenza A2 virus. | J Virol | 1970 | https://conductscience.org/library/papers/4914627 | PubMed |
| 5 | 4,981,077 | New virus-specific antigens in cells infected with influenza virus. | Virology | 1969 | https://conductscience.org/library/papers/4981077 | PubMed |
| 6 | 4,623,638 | Evidence for a new type-specific structural antigen of the influenza virus particle. | J Gen Virol | 1972 | https://conductscience.org/library/papers/4623638 | PubMed |
| 7 | 959,113 | The role of humoral immunity in host defence against influenza A infection in mice. | Postgrad Med J | 1976 | https://conductscience.org/library/papers/959113 | PubMed |
| 8 | 4,602,223 | Movement of virus-induced antigens on the cell surface. | Arch Gesamte Virusforsch | 1973 | https://conductscience.org/library/papers/4602223 | PubMed |
| 9 | 4,752,847 | The effect of bursectomy and thymectomy on the course of avian influenza virus infection. | Cell Immunol | 1973 | https://conductscience.org/library/papers/4752847 | PubMed |
| 10 | 4,543,055 | Vaccination and protection experiments in mice with the human A-1957 and A-1968 strains, and the Equi-2 strain of influenza virus. | Antonie Van Leeuwenhoek | 1973 | https://conductscience.org/library/papers/4543055 | PubMed |
| 12 | 4,998,414 | The polypeptide composition of influenza A viruses. | Virology | 1971 | https://conductscience.org/library/papers/4998414 | PubMed |
| 13 | 14,255,658 | INDUCTION OF PARTIAL SPECIFIC HETEROTYPIC IMMUNITY IN MICE BY A SINGLE INFECTION WITH INFLUENZA A VIRUS. | J Bacteriol | 1965 | https://conductscience.org/library/papers/14255658 | PubMed |
Cited by39
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 92 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,269,835 | Hijacking the host heparan sulfate-cell-surface ribonucleoproteins (RNPs) scaffold pathway for viral immune evasion. | Virol Sin | 2026 | https://conductscience.org/library/papers/42269835 | PubMed |
| 41,659,501 | The Unexpected Visibility of the SARS-CoV-2 Nucleocapsid Protein Reveals a Hidden Route of Surface Trafficking. | bioRxiv | 2026 | https://conductscience.org/library/papers/41659501 | PubMed |
| 40,295,865 | Cell surface RNA virus nucleocapsid proteins: a viral strategy for immunosuppression? | Npj Viruses | 2024 | https://conductscience.org/library/papers/40295865 | PubMed |
| 38,140,152 | Nucleoprotein as a Promising Antigen for Broadly Protective Influenza Vaccines. | Vaccines (Basel) | 2023 | https://conductscience.org/library/papers/38140152 | PubMed |
| 37,916,834 | Characterization of non-neutralizing human monoclonal antibodies that target the M1 and NP of influenza A viruses. | J Virol | 2023 | https://conductscience.org/library/papers/37916834 | PubMed |
| 37,399,385 | Cell surface nucleocapsid protein expression: A betacoronavirus immunomodulatory strategy. | Proc Natl Acad Sci U S A | 2023 | https://conductscience.org/library/papers/37399385 | PubMed |
| 35,587,364 | SARS-CoV-2 host-shutoff impacts innate NK cell functions, but antibody-dependent NK activity is strongly activated through non-spike antibodies. | Elife | 2022 | https://conductscience.org/library/papers/35587364 | PubMed |
| 35,336,928 | The Role of Nucleoprotein in Immunity to Human Negative-Stranded RNA Viruses-Not Just Another Brick in the Viral Nucleocapsid. | Viruses | 2022 | https://conductscience.org/library/papers/35336928 | PubMed |
| 34,925,355 | A Host-Restricted Self-Attenuated Influenza Virus Provides Broad Pan-Influenza A Protection in a Mouse Model. | Front Immunol | 2021 | https://conductscience.org/library/papers/34925355 | PubMed |
| 33,916,924 | Immune Responses Elicited by Live Attenuated Influenza Vaccines as Correlates of Universal Protection against Influenza Viruses. | Vaccines (Basel) | 2021 | https://conductscience.org/library/papers/33916924 | PubMed |
| 32,811,334 | Protein transduction domain-mediated influenza NP subunit vaccine generates a potent immune response and protection against influenza virus in mice. | Emerg Microbes Infect | 2020 | https://conductscience.org/library/papers/32811334 | PubMed |
| 32,719,124 | Kinetically distinct processing pathways diversify the CD8+ T cell response to a single viral epitope. | Proc Natl Acad Sci U S A | 2020 | https://conductscience.org/library/papers/32719124 | PubMed |
| 32,121,563 | Influenza A Virus Antibodies with Antibody-Dependent Cellular Cytotoxicity Function. | Viruses | 2020 | https://conductscience.org/library/papers/32121563 | PubMed |
| 31,993,232 | Non-neutralizing Antibodies Directed at Conservative Influenza Antigens. | Acta Naturae | 2019 | https://conductscience.org/library/papers/31993232 | PubMed |
| 31,379,866 | Protective Antibodies Against Influenza Proteins. | Front Immunol | 2019 | https://conductscience.org/library/papers/31379866 | PubMed |
| 29,701,840 | A Lipid/DNA Adjuvant-Inactivated Influenza Virus Vaccine Protects Rhesus Macaques From Uncontrolled Virus Replication After Heterosubtypic Influenza A Virus Challenge. | J Infect Dis | 2018 | https://conductscience.org/library/papers/29701840 | PubMed |
| 27,428,437 | What Lies Beneath: Antibody Dependent Natural Killer Cell Activation by Antibodies to Internal Influenza Virus Proteins. | EBioMedicine | 2016 | https://conductscience.org/library/papers/27428437 | PubMed |
| 26,343,187 | Developing Universal Influenza Vaccines: Hitting the Nail, Not Just on the Head. | Vaccines (Basel) | 2015 | https://conductscience.org/library/papers/26343187 | PubMed |
| 24,971,078 | Universal immunity to influenza must outwit immune evasion. | Front Microbiol | 2014 | https://conductscience.org/library/papers/24971078 | PubMed |
| 24,109,221 | Standard trivalent influenza virus protein vaccination does not prime antibody-dependent cellular cytotoxicity in macaques. | J Virol | 2013 | https://conductscience.org/library/papers/24109221 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/840296
GET https://conductscience.org/api/papers/v1/840296/cited_by?page=2